PPARγ agonist
Showing 1 - 25 of 1,715
Anaplastic Thyroid Cancer Trial in United States (CS-7017, Paclitaxel)
Terminated
- Anaplastic Thyroid Cancer
-
Aurora, Colorado
- +9 more
Aug 31, 2020
Polycystic Ovary Syndrome, Chiglitazar, Metformin Trial in Shenyang (Chiglitazar, Metformin)
Enrolling by invitation
- Polycystic Ovary Syndrome
- +2 more
-
Shenyang, Liaoning, ChinaShengjing Hospital of China Medical University
Nov 5, 2023
Polycystic Ovary Syndrome Trial in Sherbrooke (Rosiglitazone, Acarbose)
Completed
- Polycystic Ovary Syndrome
-
Sherbrooke, Quebec, CanadaUniversité de Sherbrooke
Jan 4, 2022
Malaria Trial in Manhiça (Rosiglitazone, Placebo)
Unknown status
- Malaria
- Rosiglitazone
- Placebo
-
Manhiça, Maputo, MozambiqueCentro de Investigação em Saude da Manhiça
Jan 26, 2021
Diabetes Type 2 Trial in Seongnam (Dapagliflozin 10mg Tab, Lobeglitazone 0.5 mg, Dapagliflozin + Lobeglitazone)
Recruiting
- Diabetes Type 2
- Dapagliflozin 10mg Tab
- +2 more
-
Seongnam, Gyeonggi, Korea, Republic ofSeoul National University Bundang Hospital
Jun 14, 2023
Obesity Trial in Rochester (Immediate weight loss, Pioglitazone, Deferred weight loss)
Recruiting
- Obesity
- Immediate weight loss
- +3 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Oct 6, 2021
Cocaine Use Disorder, Alcohol Use Disorder Trial in Houston (Pioglitazone, Placebo, Therapy)
Completed
- Cocaine Use Disorder
- Alcohol Use Disorder
- Pioglitazone
- +3 more
-
Houston, TexasThe University of Texas Health Science Center at Houston
Mar 26, 2018
Non Alcoholic Steatohepatitis Trial in Tanta (Pioglitazone 30mg, Empagliflozin 10 MG)
Not yet recruiting
- Non Alcoholic Steatohepatitis
- Pioglitazone 30mg
- Empagliflozin 10 MG
-
Tanta, Gharbiya, EgyptTanta University
Nov 2, 2022
Melanoma, NSCLC, Hepatocellular Carcinoma Trial in Pittsburgh (Nivolumab or Pembrolizumab (dependent upon approved indication),
Recruiting
- Melanoma
- +7 more
- Nivolumab or Pembrolizumab (dependent upon approved indication)
- +2 more
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Feb 10, 2022
Ovarian Stimulation, Human Chorionic Gonadotropin, Oocyte Donors Trial in Thessaloniki (Dual trigger (human chorionic
Recruiting
- Ovarian Stimulation
- +2 more
- Dual trigger (human chorionic gonadotropin plus GnRH-agonist)
- GnRH-agonist only trigger
-
Thessaloniki, GreeceEmbryolab Fertility Clinic
Nov 20, 2023
Hair Diseases, Alopecia, Hair Loss Trial in Manaus (DA-OTC-002)
Completed
- Hair Diseases
- +2 more
- DA-OTC-002
-
Manaus, BrazilHospital Oscar Nicolau
Oct 20, 2023
Type 2 Diabetes, Diabetes, Type 2 Trial (Tirzepatide)
Not yet recruiting
- Type 2 Diabetes
- Diabetes Mellitus, Type 2
- (no location specified)
Feb 6, 2023
Arterial Stiffness, Hypertension, Cardiovascular Diseases Trial in Prague (Cardiovascular fitness)
Active, not recruiting
- Arterial Stiffness
- +2 more
- Cardiovascular fitness
-
Prague, Czechia
- +1 more
Sep 14, 2023
Sepsis Complicated With ARDS Trial in Tianjin (Blood samples and alveolar lavage fluid were collected)
Recruiting
- Sepsis Complicated With ARDS
- Blood samples and alveolar lavage fluid were collected
-
Tianjin, Tianjin, ChinaPlasma and alveolar lavage fluid
Jul 24, 2022
Advanced Solid Tumor, Locally Advanced Solid Tumor, Metastatic Solid Tumor Trial in Australia, United States (TransCon TLR7/8
Recruiting
- Advanced Solid Tumor
- +6 more
- TransCon TLR7/8 Agonist
- Pembrolizumab
-
Duarte, California
- +12 more
Sep 21, 2022
Exercise Performance Trial in Copenhagen (Indacaterol and Mometasonefluroate (low dose), Placebo, Indacaterol and
Recruiting
- Exercise Performance
- Indacaterol and Mometasonefluroate (low dose)
- +2 more
-
Copenhagen, DenmarkAugust Krogh Building
Oct 4, 2023
Incidence of Retained Gastric Food on Endoscopy
Not yet recruiting
- Gastric Content Aspiration
- Esophagogastroduodenoscopy
- (no location specified)
May 16, 2023
Exercise Performance Trial in Copenhagen (Vilanterol and Fluticasone Furoate (low dose), Vilanterol and Fluticasone Furoate
Recruiting
- Exercise Performance
- Vilanterol and Fluticasone Furoate (low dose)
- +2 more
-
Copenhagen, DK, DenmarkAugust Krogh Building
Sep 27, 2023
Breast Cancer, Early-stage Breast Cancer, High Risk Breast Carcinoma Trial in United States (Abemaciclib, Tamoxifen,
Not yet recruiting
- Breast Cancer
- +2 more
- Abemaciclib
- +5 more
-
Boston, Massachusetts
- +7 more
Aug 14, 2023
Pulmonary Arterial Hypertension Trial in Tempe (Prostacyclin Receptor Agonist)
Recruiting
- Pulmonary Arterial Hypertension
- Prostacyclin Receptor Agonist
-
Tempe, ArizonaCelerion
Aug 16, 2022
Effects of GLP-1 Agonists on Gastric Volume
Not yet recruiting
- Diabetes
- +3 more
- Gastric Ultrasound
-
Charleston, South CarolinaMedical University of South Carolina
May 10, 2023